The biopharma industry has shed tens of thousands over the past few years. This significant churn rate has created a breeding ground for intellectual property (IP) theft, leaving companies vulnerable both as they lose and gain employees. “Any time you have a situation where there are a lot of employees in a position where they…
Strategies for tapping the cloud to scale data transformation in biopharma
Biopharma’s gradual embrace of the cloud is picking up pace. In 2022, PwC surveyed more than one hundred pharmaceutical and life sciences companies. Forty percent were already running all of their operations in the cloud; another 55% hoped to join them by late this year. The report also found that the most successful companies used…